share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

SEC announcement ·  Jun 14 16:21
Summary by Moomoo AI
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more